Neogen Chemicals

Expanding Lithium Battery Materials Will Secure Global Reach

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

15 Mar 25

Updated

11 Dec 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-49.8%

7D

7.2%

Loading

1Y

-49.8%

7D

7.2%

You can edit this narrative until Dec 12 11:15 PM. Then, changes will post as Updates.

Author's Valuation

₹1.81k40.5% undervalued

AnalystConsensusTarget Fair Value

Shared on 11 Dec 25

Fair value Increased 0.32%

NEOGEN: Market Perform Initiation Will Support Steady Future Return Potential

Analysts have nudged their price target for Neogen Chemicals slightly higher, reflecting a modest improvement in fair value to roughly ₹1,812 per share. This is supported by expectations of sustained high revenue growth and stable valuation multiples, despite only minor adjustments to discount rate and profit margin assumptions.

Shared on 27 Nov 25

NEOGEN: Broader Customer Base And Joint Venture Will Support Steady Future Returns

Analysts have maintained Neogen Chemicals' price target at $1,806.57, citing stable growth expectations and aligning their assessment with the recent initiation of a Market Perform rating by the Street. Analyst Commentary Bullish Takeaways Bullish analysts note Neogen Chemicals' consistent revenue growth, which supports the current valuation and underpins the stable price target.

Shared on 12 Nov 25

Fair value Decreased 12%

NEOGEN: Product Diversification Will Drive Long-Term Returns After New Joint Venture

Analysts have revised Neogen Chemicals' fair value target downward from ₹2,062.83 to ₹1,806.57. This adjustment is due to a slightly higher discount rate and moderated revenue growth expectations, as reflected in recent research updates.

Shared on 06 Aug 25

Fair value Decreased 6.23%

Despite an upward revision in revenue growth forecasts, Neogen Chemicals’ consensus price target has been lowered to ₹2,062, primarily due to a substantial decline in its future P/E multiple. What's in the News Annual dividend decreased to INR 1 per share for FY 2024-25.

Shared on 01 May 25

Fair value Decreased 2.27%

Shared on 24 Apr 25

Fair value Decreased 0.70%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Increased 4.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 4.40%

Shared on 26 Mar 25

Fair value Decreased 4.93%

AnalystConsensusTarget has decreased revenue growth from 51.0% to 44.3%.

Shared on 19 Mar 25

Fair value Increased 10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

₹1.81k

40.5% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

31.94%

Chemicals revenue growth rate

0.61%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

14.38%

Calculation

₹1.96b

Earnings '28

x

35.88x

PE Ratio '28

=

₹70.46b

Market Cap '28

₹70.46b

Market Cap '28

/

26.29m

No. shares '28

=

₹2.68k

Share Price '28

₹2.68k Share Price '28

Discounted to 2025 @ 14.36% p.a.

=

₹1.79k

Fair Value '25